BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21527555)

  • 1. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.
    Ramsey MR; He L; Forster N; Ory B; Ellisen LW
    Cancer Res; 2011 Jul; 71(13):4373-9. PubMed ID: 21527555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells.
    Gallant-Behm CL; Espinosa JM
    Cell Cycle; 2013 Feb; 12(3):409-16. PubMed ID: 23324337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
    Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
    Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma.
    Pokorna Z; Vyslouzil J; Vojtesek B; Coates PJ
    Cell Mol Biol Lett; 2022 Feb; 27(1):18. PubMed ID: 35196980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.
    Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C
    Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
    Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
    Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
    Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
    PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation.
    Qian Y; Jung YS; Chen X
    J Biol Chem; 2011 Apr; 286(14):12033-41. PubMed ID: 21317427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
    J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression.
    Lebrun-Julien F; Suter U
    ASN Neuro; 2015; 7(3):. PubMed ID: 26129908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.
    Sacco JJ; Kenyani J; Butt Z; Carter R; Chew HY; Cheeseman LP; Darling S; Denny M; Urbé S; Clague MJ; Coulson JM
    Oncotarget; 2015 May; 6(15):13757-71. PubMed ID: 25970771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells.
    LeBoeuf M; Terrell A; Trivedi S; Sinha S; Epstein JA; Olson EN; Morrisey EE; Millar SE
    Dev Cell; 2010 Dec; 19(6):807-18. PubMed ID: 21093383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.
    Sinha S; Malonia SK; Mittal SP; Singh K; Kadreppa S; Kamat R; Mukhopadhyaya R; Pal JK; Chattopadhyay S
    EMBO J; 2010 Feb; 29(4):830-42. PubMed ID: 20075864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
    Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
    Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of STAT1-Driven Transcriptional Activity by Histone Deacetylases.
    Owusu BY; Klampfer L
    Methods Mol Biol; 2017; 1510():277-285. PubMed ID: 27761828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.
    Heideman MR; Wilting RH; Yanover E; Velds A; de Jong J; Kerkhoven RM; Jacobs H; Wessels LF; Dannenberg JH
    Blood; 2013 Mar; 121(11):2038-50. PubMed ID: 23327920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.